Phase 2A

Phase 2A

A controlled clinical study carried out after completing Phase-1 studies. It is the first set of exposure-response studies in patients, and is carried out before beginning Phase 2B (the patient dose-ranging trial) and Phase 3 (clinical efficacy-safety studies).